{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T06:18:45Z","timestamp":1769149125063,"version":"3.49.0"},"publisher-location":"Singapore","reference-count":105,"publisher":"Springer Singapore","isbn-type":[{"value":"9789811373411","type":"print"},{"value":"9789811373428","type":"electronic"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1007\/978-981-13-7342-8_9","type":"book-chapter","created":{"date-parts":[[2019,7,23]],"date-time":"2019-07-23T11:03:32Z","timestamp":1563879812000},"page":"191-215","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Leukemia Stem Cells in Chronic Myeloid Leukemia"],"prefix":"10.1007","author":[{"given":"Yi","family":"Shan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ngoc","family":"DeSouza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaoguang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,7,24]]},"reference":[{"key":"9_CR1","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1034\/j.1600-065X.2002.18707.x","volume":"187","author":"D Allman","year":"2002","unstructured":"Allman D, Aster JC, Pear WS (2002) Notch signaling in hematopoiesis and early lymphocyte development. Immunol Rev 187:75\u201386","journal-title":"Immunol Rev"},{"key":"9_CR2","first-page":"355","volume":"11","author":"WG An","year":"2000","unstructured":"An WG, Schulte TW, Neckers LM (2000) The heat shock protein 90 antagonist geldanamycin alters chaperone association with p210bcr-abl and v-src proteins before their degradation by the proteasome. Cell Growth Differ 11:355\u2013360","journal-title":"Cell Growth Differ"},{"key":"9_CR3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1158\/1078-0432.CCR-08-0132","volume":"15","author":"U Banerji","year":"2009","unstructured":"Banerji U (2009) Heat shock protein 90 as a drug target: some like it hot. Clin Cancer Res 15:9\u201314","journal-title":"Clin Cancer Res"},{"key":"9_CR4","doi-asserted-by":"publisher","first-page":"2862","DOI":"10.4161\/cc.5.24.3573","volume":"5","author":"DJ Barnes","year":"2006","unstructured":"Barnes DJ, Melo JV (2006) Primitive, quiescent and difficult to kill: the role of non-proliferating stem cells in chronic myeloid leukemia. Cell Cycle 5:2862\u20132866","journal-title":"Cell Cycle"},{"key":"9_CR5","doi-asserted-by":"publisher","first-page":"4701","DOI":"10.1182\/blood-2002-09-2780","volume":"101","author":"R Bhatia","year":"2003","unstructured":"Bhatia R, Holtz M, Niu N, Gray R, Snyder DS, Sawyers CL, Arber DA, Slovak ML, Forman SJ (2003) Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment. Blood 101:4701\u20134707","journal-title":"Blood"},{"key":"9_CR6","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s00277-008-0603-8","volume":"88","author":"J Bhattacharyya","year":"2009","unstructured":"Bhattacharyya J, Mihara K, Yasunaga S, Tanaka H, Hoshi M, Takihara Y, Kimura A (2009) BMI-1 expression is enhanced through transcriptional and posttranscriptional regulation during the progression of chronic myeloid leukemia. Ann Hematol 88:333\u2013340","journal-title":"Ann Hematol"},{"key":"9_CR7","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/nm0797-730","volume":"3","author":"D Bonnet","year":"1997","unstructured":"Bonnet D, Dick JE (1997) Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 3:730\u2013737","journal-title":"Nat Med"},{"key":"9_CR8","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1038\/sj.leu.2404388","volume":"20","author":"S Branford","year":"2006","unstructured":"Branford S, Cross NC, Hochhaus A, Radich J, Saglio G, Kaeda J, Goldman J, Hughes T (2006) Rationale for the recommendations for harmonizing current methodology for detecting BCR-ABL transcripts in patients with chronic myeloid leukaemia. Leukemia 20:1925\u20131930","journal-title":"Leukemia"},{"key":"9_CR9","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/sj.emboj.7600502","volume":"24","author":"A Catalano","year":"2005","unstructured":"Catalano A, Rodilossi S, Caprari P, Coppola V, Procopio A (2005) 5-lipoxygenase regulates senescence-like growth arrest by promoting ROS-dependent p53 activation. EMBO J 24:170\u2013179","journal-title":"EMBO J"},{"key":"9_CR10","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1182\/blood-2016-10-745588","volume":"130","author":"G Cheloni","year":"2017","unstructured":"Cheloni G, Tanturli M, Tusa I, Ho DeSouza N, Shan Y, Gozzini A, Mazurier F, Rovida E, Li S, Dello Sbarba P (2017) Targeting chronic myeloid leukemia stem cells with the hypoxia-inducible factor inhibitor acriflavine. Blood 130:655\u2013665","journal-title":"Blood"},{"key":"9_CR11","doi-asserted-by":"crossref","first-page":"10073","DOI":"10.18632\/oncotarget.7164","volume":"7","author":"K Chen","year":"2016","unstructured":"Chen K, Yang J, Li J, Wang X, Chen Y, Huang S, Chen JL (2016) eIF4B is a convergent target and critical effector of oncogenic Pim and PI3K\/Akt\/mTOR signaling pathways in Abl transformants. Oncotarget 7:10073\u201310089","journal-title":"Oncotarget"},{"key":"9_CR12","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/372179a0","volume":"372","author":"XS Chen","year":"1994","unstructured":"Chen XS, Sheller JR, Johnson EN, Funk CD (1994) Role of leukotrienes revealed by targeted disruption of the 5-lipoxygenase gene. Nature 372:179\u2013182","journal-title":"Nature"},{"key":"9_CR13","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/ng.389","volume":"41","author":"Y Chen","year":"2009","unstructured":"Chen Y, Hu Y, Zhang H, Peng C, Li S (2009) Loss of the Alox5 gene impairs leukemia stem cells and prevents chronic myeloid leukemia. Nat Genet 41:783\u2013792","journal-title":"Nat Genet"},{"key":"9_CR14","first-page":"177","volume":"7","author":"Y Chen","year":"2014","unstructured":"Chen Y, Li S (2014) Omacetaxine mepesuccinate in the treatment of intractable chronic myeloid leukemia. Oncol Targets Ther 7:177\u2013186","journal-title":"Oncol Targets Ther"},{"key":"9_CR15","doi-asserted-by":"publisher","first-page":"3847","DOI":"10.1172\/JCI66129","volume":"124","author":"Y Chen","year":"2014","unstructured":"Chen Y, Peng C, Abraham SA, Shan Y, Guo Z, Desouza N, Cheloni G, Li D, Holyoake TL, Li S (2014) Arachidonate 15-lipoxygenase is required for chronic myeloid leukemia stem cell survival. J Clin Invest 124:3847\u20133862","journal-title":"J Clin Invest"},{"key":"9_CR16","doi-asserted-by":"publisher","first-page":"35293","DOI":"10.18632\/oncotarget.9182","volume":"7","author":"JC Chomel","year":"2016","unstructured":"Chomel JC, Bonnet ML, Sorel N, Sloma I, Bennaceur-Griscelli A, Rea D, Legros L, Marfaing-Koka A, Bourhis JH, Ame S et al (2016) Leukemic stem cell persistence in chronic myeloid leukemia patients in deep molecular response induced by tyrosine kinase inhibitors and the impact of therapy discontinuation. Oncotarget 7:35293\u201335301","journal-title":"Oncotarget"},{"key":"9_CR17","doi-asserted-by":"publisher","first-page":"5565","DOI":"10.1182\/blood-2010-12-327437","volume":"118","author":"S Chu","year":"2011","unstructured":"Chu S, McDonald T, Lin A, Chakraborty S, Huang Q, Snyder DS, Bhatia R (2011) Persistence of leukemia stem cells in chronic myelogenous leukemia patients in prolonged remission with imatinib treatment. Blood 118:5565\u20135572","journal-title":"Blood"},{"key":"9_CR18","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1182\/blood-2004-03-1114","volume":"105","author":"S Chu","year":"2005","unstructured":"Chu S, Xu H, Shah NP, Snyder DS, Forman SJ, Sawyers CL, Bhatia R (2005) Detection of BCR-ABL kinase mutations in CD34+ cells from chronic myelogenous leukemia patients in complete cytogenetic remission on imatinib mesylate treatment. Blood 105:2093\u20132098","journal-title":"Blood"},{"key":"9_CR19","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1084\/jem.20031615","volume":"199","author":"M Cobas","year":"2004","unstructured":"Cobas M, Wilson A, Ernst B, Mancini SJ, MacDonald HR, Kemler R, Radtke F (2004) Beta-catenin is dispensable for hematopoiesis and lymphopoiesis. J Exp Med 199:221\u2013229","journal-title":"J Exp Med"},{"key":"9_CR20","doi-asserted-by":"publisher","first-page":"4532","DOI":"10.1182\/blood-2005-07-2947","volume":"107","author":"M Copland","year":"2006","unstructured":"Copland M, Hamilton A, Elrick LJ, Baird JW, Allan EK, Jordanides N, Barow M, Mountford JC, Holyoake TL (2006) Dasatinib (BMS-354825) targets an earlier progenitor population than imatinib in primary CML but does not eliminate the quiescent fraction. Blood 107:4532\u20134539","journal-title":"Blood"},{"key":"9_CR21","doi-asserted-by":"publisher","first-page":"6884","DOI":"10.1158\/0008-5472.CAN-08-1101","volume":"68","author":"K Cramer","year":"2008","unstructured":"Cramer K, Nieborowska-Skorska M, Koptyra M, Slupianek A, Penserga ET, Eaves CJ, Aulitzky W, Skorski T (2008) BCR\/ABL and other kinases from chronic myeloproliferative disorders stimulate single-strand annealing, an unfaithful DNA double-strand break repair. Cancer Res 68:6884\u20136888","journal-title":"Cancer Res"},{"key":"9_CR22","doi-asserted-by":"publisher","first-page":"981679","DOI":"10.1155\/2009\/981679","volume":"2009","author":"B Culjkovic","year":"2009","unstructured":"Culjkovic B, Borden KL (2009) Understanding and targeting the eukaryotic translation initiation factor eIF4E in head and neck cancer. J Oncol 2009:981679","journal-title":"J Oncol"},{"key":"9_CR23","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.4161\/cc.10.8.15326","volume":"10","author":"C Culver","year":"2011","unstructured":"Culver C, Melvin A, Mudie S, Rocha S (2011) HIF-1alpha depletion results in SP1-mediated cell cycle disruption and alters the cellular response to chemotherapeutic drugs. Cell Cycle 10:1249\u20131260","journal-title":"Cell Cycle"},{"key":"9_CR24","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1124\/pr.55.3.4","volume":"55","author":"MW Deininger","year":"2003","unstructured":"Deininger MW, Druker BJ (2003) Specific targeted therapy of chronic myelogenous leukemia with imatinib. Pharmacol Rev 55:401\u2013423","journal-title":"Pharmacol Rev"},{"key":"9_CR25","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.ccr.2008.08.003","volume":"14","author":"C Dierks","year":"2008","unstructured":"Dierks C, Beigi R, Guo GR, Zirlik K, Stegert MR, Manley P, Trussell C, Schmitt-Graeff A, Landwerlin K, Veelken H et al (2008) Expansion of Bcr-Abl-positive leukemic stem cells is dependent on Hedgehog pathway activation. Cancer Cell 14:238\u2013249","journal-title":"Cancer Cell"},{"issue":"Suppl 1","key":"9_CR26","first-page":"S14","volume":"7","author":"BJ Druker","year":"2001","unstructured":"Druker BJ (2001) Current treatment approaches for chronic myelogenous leukemia. Cancer J 7(Suppl 1):S14\u2013S18","journal-title":"Cancer J"},{"key":"9_CR27","doi-asserted-by":"publisher","first-page":"4808","DOI":"10.1182\/blood-2008-07-077958","volume":"112","author":"BJ Druker","year":"2008","unstructured":"Druker BJ (2008) Translation of the Philadelphia chromosome into therapy for CML. Blood 112:4808\u20134817","journal-title":"Blood"},{"key":"9_CR28","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/nm0596-561","volume":"2","author":"BJ Druker","year":"1996","unstructured":"Druker BJ, Tamura S, Buchdunger E, Ohno S, Segal GM, Fanning S, Zimmermann J, Lydon NB (1996) Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells. Nat Med 2:561\u2013566","journal-title":"Nat Med"},{"key":"9_CR29","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/ni1164","volume":"6","author":"AW Duncan","year":"2005","unstructured":"Duncan AW, Rattis FM, DiMascio LN, Congdon KL, Pazianos G, Zhao C, Yoon K, Cook JM, Willert K, Gaiano N et al (2005) Integration of Notch and Wnt signaling in hematopoietic stem cell maintenance. Nat Immunol 6:314\u2013322","journal-title":"Nat Immunol"},{"key":"9_CR30","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1056\/NEJM199907153410306","volume":"341","author":"S Faderl","year":"1999","unstructured":"Faderl S, Talpaz M, Estrov Z, O\u2019Brien S, Kurzrock R, Kantarjian HM (1999) The biology of chronic myeloid leukemia. N Engl J Med 341:164\u2013172","journal-title":"N Engl J Med"},{"key":"9_CR31","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1093\/carcin\/23.11.1933","volume":"23","author":"FS Falvella","year":"2002","unstructured":"Falvella FS, Pascale RM, Gariboldi M, Manenti G, De Miglio MR, Simile MM, Dragani TA, Feo F (2002) Stearoyl-CoA desaturase 1 (Scd1) gene overexpression is associated with genetic predisposition to hepatocarcinogenesis in mice and rats. Carcinogenesis 23:1933\u20131936","journal-title":"Carcinogenesis"},{"key":"9_CR32","doi-asserted-by":"publisher","first-page":"e377","DOI":"10.1038\/bcj.2015.109","volume":"6","author":"E Glodkowska-Mrowka","year":"2016","unstructured":"Glodkowska-Mrowka E, Manda-Handzlik A, Stelmaszczyk-Emmel A, Seferynska I, Stoklosa T, Przybylski J, Mrowka P (2016) PPARgamma ligands increase antileukemic activity of second- and third-generation tyrosine kinase inhibitors in chronic myeloid leukemia cells. Blood Cancer J 6:e377","journal-title":"Blood Cancer J"},{"key":"9_CR33","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1182\/blood-2009-02-206722","volume":"114","author":"A Gutierrez","year":"2009","unstructured":"Gutierrez A, Sanda T, Grebliunaite R, Carracedo A, Salmena L, Ahn Y, Dahlberg S, Neuberg D, Moreau LA, Winter SS et al (2009) High frequency of PTEN, PI3K, and AKT abnormalities in T-cell acute lymphoblastic leukemia. Blood 114:647\u2013650","journal-title":"Blood"},{"key":"9_CR34","doi-asserted-by":"publisher","first-page":"4436","DOI":"10.1182\/blood-2007-05-088815","volume":"110","author":"ML Guzman","year":"2007","unstructured":"Guzman ML, Li X, Corbett CA, Rossi RM, Bushnell T, Liesveld JL, Hebert J, Young F, Jordan CT (2007) Rapid and selective death of leukemia stem and progenitor cells induced by the compound 4-benzyl, 2-methyl, 1,2,4-thiadiazolidine, 3,5 dione (TDZD-8). Blood 110:4436\u20134444","journal-title":"Blood"},{"key":"9_CR35","doi-asserted-by":"publisher","first-page":"4163","DOI":"10.1182\/blood-2004-10-4135","volume":"105","author":"ML Guzman","year":"2005","unstructured":"Guzman ML, Rossi RM, Karnischky L, Li X, Peterson DR, Howard DS, Jordan CT (2005) The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells. Blood 105:4163\u20134169","journal-title":"Blood"},{"key":"9_CR36","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1053\/shem.2003.50039","volume":"40","author":"EA Hahn","year":"2003","unstructured":"Hahn EA, Glendenning GA (2003) Quality of life on imatinib. Semin Hematol 40:31\u201336","journal-title":"Semin Hematol"},{"key":"9_CR37","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s12185-011-0901-0","volume":"94","author":"FH Heidel","year":"2011","unstructured":"Heidel FH, Mar BG, Armstrong SA (2011) Self-renewal related signaling in myeloid leukemia stem cells. Int J Hematol 94:109\u2013117","journal-title":"Int J Hematol"},{"key":"9_CR38","doi-asserted-by":"publisher","first-page":"e11394","DOI":"10.1371\/journal.pone.0011394","volume":"5","author":"D Hess","year":"2010","unstructured":"Hess D, Chisholm JW, Igal RA (2010) Inhibition of stearoylCoA desaturase activity blocks cell cycle progression and induces programmed cell death in lung cancer cells. PLoS One 5:e11394","journal-title":"PLoS One"},{"key":"9_CR39","doi-asserted-by":"publisher","first-page":"3792","DOI":"10.1182\/blood.V99.10.3792","volume":"99","author":"MS Holtz","year":"2002","unstructured":"Holtz MS, Slovak ML, Zhang F, Sawyers CL, Forman SJ, Bhatia R (2002) Imatinib mesylate (STI571) inhibits growth of primitive malignant progenitors in chronic myelogenous leukemia through reversal of abnormally increased proliferation. Blood 99:3792\u20133800","journal-title":"Blood"},{"key":"9_CR40","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1182\/blood.V94.6.2056","volume":"94","author":"T Holyoake","year":"1999","unstructured":"Holyoake T, Jiang X, Eaves C, Eaves A (1999a) Isolation of a highly quiescent subpopulation of primitive leukemic cells in chronic myeloid leukemia. Blood 94:2056\u20132064","journal-title":"Blood"},{"key":"9_CR41","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1016\/S0301-472X(99)00078-8","volume":"27","author":"TL Holyoake","year":"1999","unstructured":"Holyoake TL, Nicolini FE, Eaves CJ (1999b) Functional differences between transplantable human hematopoietic stem cells from fetal liver, cord blood, and adult marrow. Exp Hematol 27:1418\u20131427","journal-title":"Exp Hematol"},{"key":"9_CR42","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1182\/blood-2016-09-696013","volume":"129","author":"TL Holyoake","year":"2017","unstructured":"Holyoake TL, Vetrie D (2017) The chronic myeloid leukemia stem cell: stemming the tide of persistence. Blood 129:1595\u20131606","journal-title":"Blood"},{"key":"9_CR43","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/leu.2008.262","volume":"23","author":"Y Hu","year":"2009","unstructured":"Hu Y, Chen Y, Douglas L, Li S (2009) Beta-catenin is essential for survival of leukemic stem cells insensitive to kinase inhibition in mice with BCR-ABL-induced chronic myeloid leukemia. Leukemia 23:109\u2013116","journal-title":"Leukemia"},{"key":"9_CR44","doi-asserted-by":"publisher","first-page":"16870","DOI":"10.1073\/pnas.0606509103","volume":"103","author":"Y Hu","year":"2006","unstructured":"Hu Y, Swerdlow S, Duffy TM, Weinmann R, Lee FY, Li S (2006) Targeting multiple kinase pathways in leukemic progenitors and stem cells is essential for improved treatment of Ph+ leukemia in mice. Proc Natl Acad Sci U S A 103:16870\u201316875","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9_CR45","doi-asserted-by":"crossref","unstructured":"Ingham PW et al (2001) Hedgehog signaling: a tale of two lipids. Science 294(5548):1879\u20131881. PMID:11729305","DOI":"10.1126\/science.1064115"},{"key":"9_CR46","first-page":"357027","volume":"2014","author":"N Iqbal","year":"2014","unstructured":"Iqbal N, Iqbal N (2014) Imatinib: a breakthrough of targeted therapy in cancer. Chemother Res Pract 2014:357027","journal-title":"Chemother Res Pract"},{"key":"9_CR47","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/bmt.2009.11","volume":"44","author":"DA Irvine","year":"2009","unstructured":"Irvine DA, Shepherd JD (2009) Recurrence of lymphoid blast crisis over 20 years after successful sibling allo-SCT for CML: short lived complete cytogenetic response to imatinib. Bone Marrow Transplant 44:267\u2013268","journal-title":"Bone Marrow Transplant"},{"key":"9_CR48","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/S1535-6108(03)00029-1","volume":"3","author":"JS Isaacs","year":"2003","unstructured":"Isaacs JS, Xu W, Neckers L (2003) Heat shock protein 90 as a molecular target for cancer therapeutics. Cancer Cell 3:213\u2013217","journal-title":"Cancer Cell"},{"key":"9_CR49","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1038\/nature07016","volume":"453","author":"K Ito","year":"2008","unstructured":"Ito K, Bernardi R, Morotti A, Matsuoka S, Saglio G, Ikeda Y, Rosenblatt J, Avigan DE, Teruya-Feldstein J, Pandolfi PP (2008) PML targeting eradicates quiescent leukaemia-initiating cells. Nature 453:1072\u20131078","journal-title":"Nature"},{"key":"9_CR50","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1097\/01.cco.0000245314.97638.d3","volume":"18","author":"E Jabbour","year":"2006","unstructured":"Jabbour E, Cortes J, Kantarjian H (2006) Novel tyrosine kinase inhibitors in chronic myelogenous leukemia. Curr Opin Oncol 18:578\u2013583","journal-title":"Curr Opin Oncol"},{"key":"9_CR51","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1056\/NEJMoa040258","volume":"351","author":"CH Jamieson","year":"2004","unstructured":"Jamieson CH, Ailles LE, Dylla SJ, Muijtjens M, Jones C, Zehnder JL, Gotlib J, Li K, Manz MG, Keating A et al (2004a) Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. N Engl J Med 351:657\u2013667","journal-title":"N Engl J Med"},{"key":"9_CR52","first-page":"531","volume":"6","author":"CH Jamieson","year":"2004","unstructured":"Jamieson CH, Weissman IL, Passegue E (2004b) Chronic versus acute myelogenous leukemia: a question of self-renewal. Cancer Cell 6:531\u2013533","journal-title":"Cancer Cell"},{"key":"9_CR53","doi-asserted-by":"publisher","first-page":"4016","DOI":"10.1182\/blood-2006-11-057521","volume":"109","author":"HG Jorgensen","year":"2007","unstructured":"Jorgensen HG, Allan EK, Jordanides NE, Mountford JC, Holyoake TL (2007) Nilotinib exerts equipotent antiproliferative effects to imatinib and does not induce apoptosis in CD34+ CML cells. Blood 109:4016\u20134019","journal-title":"Blood"},{"key":"9_CR54","first-page":"378","volume":"54","author":"J Kaminska","year":"2008","unstructured":"Kaminska J, Klimczak-Jajor E, Bany-Laszewicz U (2008) Src kinases in the process of maturation megakryocyte progenitors. Postepy Biochem 54:378\u2013383","journal-title":"Postepy Biochem"},{"key":"9_CR55","doi-asserted-by":"publisher","first-page":"4806","DOI":"10.1200\/JCO.2008.16.9953","volume":"26","author":"JS Khorashad","year":"2008","unstructured":"Khorashad JS, de Lavallade H, Apperley JF, Milojkovic D, Reid AG, Bua M, Szydlo R, Olavarria E, Kaeda J, Goldman JM et al (2008) Finding of kinase domain mutations in patients with chronic phase chronic myeloid leukemia responding to imatinib may identify those at high risk of disease progression. J Clin Oncol 26:4806\u20134813","journal-title":"J Clin Oncol"},{"key":"9_CR56","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/nature09999","volume":"473","author":"A Klinakis","year":"2011","unstructured":"Klinakis A, Lobry C, Abdel-Wahab O, Oh P, Haeno H, Buonamici S, van De Walle I, Cathelin S, Trimarchi T, Araldi E et al (2011) A novel tumour-suppressor function for the Notch pathway in myeloid leukaemia. Nature 473:230\u2013233","journal-title":"Nature"},{"key":"9_CR57","doi-asserted-by":"publisher","first-page":"3714","DOI":"10.1093\/emboj\/17.13.3714","volume":"17","author":"E Kroon","year":"1998","unstructured":"Kroon E, Krosl J, Thorsteinsdottir U, Baban S, Buchberg AM, Sauvageau G (1998) Hoxa9 transforms primary bone marrow cells through specific collaboration with Meis1a but not Pbx1b. EMBO J 17:3714\u20133725","journal-title":"EMBO J"},{"key":"9_CR58","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/367645a0","volume":"367","author":"T Lapidot","year":"1994","unstructured":"Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang T, Caceres-Cortes J, Minden M, Paterson B, Caligiuri MA, Dick JE (1994) A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367:645\u2013648","journal-title":"Nature"},{"key":"9_CR59","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nature01572","volume":"423","author":"J Lessard","year":"2003","unstructured":"Lessard J, Sauvageau G (2003) Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature 423:255\u2013260","journal-title":"Nature"},{"key":"9_CR60","doi-asserted-by":"publisher","first-page":"4936","DOI":"10.1158\/1078-0432.CCR-10-1499","volume":"17","author":"L Li","year":"2011","unstructured":"Li L, Bhatia R (2011) Stem cell quiescence. Clin Cancer Res 17:4936\u20134941","journal-title":"Clin Cancer Res"},{"key":"9_CR61","doi-asserted-by":"publisher","first-page":"E2298","DOI":"10.1073\/pnas.1301838110","volume":"110","author":"S Lim","year":"2013","unstructured":"Lim S, Saw TY, Zhang M, Janes MR, Nacro K, Hill J, Lim AQ, Chang CT, Fruman DA, Rizzieri DA et al (2013) Targeting of the MNK-eIF4E axis in blast crisis chronic myeloid leukemia inhibits leukemia stem cell function. Proc Natl Acad Sci U S A 110:E2298\u2013E2307","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9_CR62","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1126\/science.2408149","volume":"247","author":"TG Lugo","year":"1990","unstructured":"Lugo TG, Pendergast AM, Muller AJ, Witte ON (1990) Tyrosine kinase activity and transformation potency of bcr-abl oncogene products. Science 247:1079\u20131082","journal-title":"Science"},{"key":"9_CR63","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.hoc.2004.03.008","volume":"18","author":"JV Melo","year":"2004","unstructured":"Melo JV, Deininger MW (2004) Biology of chronic myelogenous leukemia\u00a0\u2013 signaling pathways of initiation and transformation. Hematol Oncol Clin North Am 18:545\u2013568. vii\u2013viii","journal-title":"Hematol Oncol Clin North Am"},{"key":"9_CR64","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/1476-4598-9-133","volume":"9","author":"O Mendez","year":"2010","unstructured":"Mendez O, Zavadil J, Esencay M, Lukyanov Y, Santovasi D, Wang SC, Newcomb EW, Zagzag D (2010) Knock down of HIF-1alpha in glioma cells reduces migration in vitro and invasion in vivo and impairs their ability to form tumor spheres. Mol Cancer 9:133","journal-title":"Mol Cancer"},{"key":"9_CR65","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1182\/blood-2008-04-148130","volume":"112","author":"M Mohty","year":"2008","unstructured":"Mohty M, Szydlo RM, Yong AS, Apperley JF, Goldman JM, Melo JV (2008) Association between BMI-1 expression, acute graft-versus-host disease, and outcome following allogeneic stem cell transplantation from HLA-identical siblings in chronic myeloid leukemia. Blood 112:2163\u20132166","journal-title":"Blood"},{"key":"9_CR66","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1101\/gad.1299505","volume":"19","author":"AV Molofsky","year":"2005","unstructured":"Molofsky AV, He S, Bydon M, Morrison SJ, Pardal R (2005) Bmi-1 promotes neural stem cell self-renewal and neural development but not mouse growth and survival by repressing the p16Ink4a and p19Arf senescence pathways. Genes Dev 19:1432\u20131437","journal-title":"Genes Dev"},{"key":"9_CR67","doi-asserted-by":"publisher","first-page":"2872","DOI":"10.1182\/blood-2009-05-222836","volume":"115","author":"F Nakahara","year":"2010","unstructured":"Nakahara F, Sakata-Yanagimoto M, Komeno Y, Kato N, Uchida T, Haraguchi K, Kumano K, Harada Y, Harada H, Kitaura J et\u00a0al (2010) Hes1 immortalizes committed progenitors and plays a role in blast crisis transition in chronic myelogenous leukemia. Blood 115:2872\u20132881","journal-title":"Blood"},{"key":"9_CR68","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.ccr.2005.10.015","volume":"8","author":"P Neviani","year":"2005","unstructured":"Neviani P, Santhanam R, Trotta R, Notari M, Blaser BW, Liu S, Mao H, Chang JS, Galietta A, Uttam A et al (2005) The tumor suppressor PP2A is functionally inactivated in blast crisis CML through the inhibitory activity of the BCR\/ABL-regulated SET protein. Cancer Cell 8:355\u2013368","journal-title":"Cancer Cell"},{"key":"9_CR69","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/ijc.28348","volume":"134","author":"C Nishioka","year":"2014","unstructured":"Nishioka C, Ikezoe T, Yang J, Nobumoto A, Kataoka S, Tsuda M, Udaka K, Yokoyama A (2014) CD82 regulates STAT5\/IL-10 and supports survival of acute myelogenous leukemia cells. Int J Cancer 134:55\u201364","journal-title":"Int J Cancer"},{"key":"9_CR70","first-page":"85","volume":"25","author":"PC Nowell","year":"1960","unstructured":"Nowell PC, Hungerford DA (1960) Chromosome studies on normal and leukemic human leukocytes. J Natl Cancer Inst 25:85\u2013109","journal-title":"J Natl Cancer Inst"},{"key":"9_CR71","first-page":"1013","volume":"27","author":"PC Nowell","year":"1961","unstructured":"Nowell PC, Hungerford DA (1961) Chromosome studies in human leukemia. II. Chronic granulocytic leukemia. J Natl Cancer Inst 27:1013\u20131035","journal-title":"J Natl Cancer Inst"},{"key":"9_CR72","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1056\/NEJMoa022457","volume":"348","author":"SG O\u2019Brien","year":"2003","unstructured":"O\u2019Brien SG, Guilhot F, Larson RA, Gathmann I, Baccarani M, Cervantes F, Cornelissen JJ, Fischer T, Hochhaus A, Hughes T et al (2003) Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia. N Engl J Med 348:994\u20131004","journal-title":"N Engl J Med"},{"key":"9_CR73","doi-asserted-by":"publisher","first-page":"156","DOI":"10.18632\/oncotarget.119","volume":"1","author":"C Peng","year":"2010","unstructured":"Peng C, Chen Y, Li D, Li S (2010) Role of Pten in leukemia stem cells. Oncotarget 1:156\u2013160","journal-title":"Oncotarget"},{"key":"9_CR74","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.4161\/cc.6.18.4722","volume":"6","author":"C Peng","year":"2007","unstructured":"Peng C, Li D, Li S (2007) Heat shock protein 90: a potential therapeutic target in leukemic progenitor and stem cells harboring mutant BCR-ABL resistant to kinase inhibitors. Cell Cycle 6:2227\u20132231","journal-title":"Cell Cycle"},{"key":"9_CR75","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1182\/blood.V88.6.2162.bloodjournal8862162","volume":"88","author":"AL Petzer","year":"1996","unstructured":"Petzer AL, Eaves CJ, Lansdorp PM, Ponchio L, Barnett MJ, Eaves AC (1996) Characterization of primitive subpopulations of normal and leukemic cells present in the blood of patients with newly diagnosed as well as established chronic myeloid leukemia. Blood 88:2162\u20132171","journal-title":"Blood"},{"key":"9_CR76","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/nature15248","volume":"525","author":"S Prost","year":"2015","unstructured":"Prost S, Relouzat F, Spentchian M, Ouzegdouh Y, Saliba J, Massonnet G, Beressi JP, Verhoeyen E, Raggueneau V, Maneglier B et al (2015) Erosion of the chronic myeloid leukaemia stem cell pool by PPARgamma agonists. Nature 525:380\u2013383","journal-title":"Nature"},{"key":"9_CR77","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1596\/neo.12230","volume":"14","author":"X Qiu","year":"2012","unstructured":"Qiu X, Guo G, Chen K, Kashiwada M, Druker BJ, Rothman PB, Chen JL (2012) A requirement for SOCS-1 and SOCS-3 phosphorylation in Bcr-Abl-induced tumorigenesis. Neoplasia 14:547\u2013558","journal-title":"Neoplasia"},{"key":"9_CR78","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1182\/blood-2008-03-144790","volume":"113","author":"A Quintas-Cardama","year":"2009","unstructured":"Quintas-Cardama A, Cortes J (2009) Molecular biology of bcr-abl1-positive chronic myeloid leukemia. Blood 113:1619\u20131630","journal-title":"Blood"},{"key":"9_CR79","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.prostaglandins.2007.01.003","volume":"83","author":"O Radmark","year":"2007","unstructured":"Radmark O, Samuelsson B (2007) 5-lipoxygenase: regulation and possible involvement in atherosclerosis. Prostaglandins Other Lipid Mediat 83:162\u2013174","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"9_CR80","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/nature01593","volume":"423","author":"T Reya","year":"2003","unstructured":"Reya T, Duncan AW, Ailles L, Domen J, Scherer DC, Willert K, Hintz L, Nusse R, Weissman IL (2003) A role for Wnt signalling in self-renewal of haematopoietic stem cells. Nature 423:409\u2013414","journal-title":"Nature"},{"key":"9_CR81","first-page":"220","volume":"289","author":"JD Rowley","year":"1973","unstructured":"Rowley JD (1973a) Chromosomal patterns in myelocytic leukemia. N Engl J Med 289:220\u2013221","journal-title":"N Engl J Med"},{"key":"9_CR82","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/243290a0","volume":"243","author":"JD Rowley","year":"1973","unstructured":"Rowley JD (1973b) Letter: a new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature 243:290\u2013293","journal-title":"Nature"},{"key":"9_CR83","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1056\/NEJM199904293401706","volume":"340","author":"CL Sawyers","year":"1999","unstructured":"Sawyers CL (1999) Chronic myeloid leukemia. N Engl J Med 340:1330\u20131340","journal-title":"N Engl J Med"},{"key":"9_CR84","doi-asserted-by":"publisher","first-page":"3530","DOI":"10.1182\/blood.V99.10.3530","volume":"99","author":"CL Sawyers","year":"2002","unstructured":"Sawyers CL, Hochhaus A, Feldman E, Goldman JM, Miller CB, Ottmann OG, Schiffer CA, Talpaz M, Guilhot F, Deininger MW et al (2002) Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study. Blood 99:3530\u20133539","journal-title":"Blood"},{"key":"9_CR85","doi-asserted-by":"publisher","first-page":"25339","DOI":"10.1074\/jbc.M501159200","volume":"280","author":"N Scaglia","year":"2005","unstructured":"Scaglia N, Igal RA (2005) Stearoyl-CoA desaturase is involved in the control of proliferation, anchorage-independent growth, and survival in human transformed cells. J Biol Chem 280:25339\u201325349","journal-title":"J Biol Chem"},{"key":"9_CR86","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/S0006-2952(98)00120-8","volume":"56","author":"T Scheibel","year":"1998","unstructured":"Scheibel T, Buchner J (1998) The Hsp90 complex\u00a0\u2013 a super-chaperone machine as a novel drug target. Biochem Pharmacol 56:675\u2013682","journal-title":"Biochem Pharmacol"},{"key":"9_CR87","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1084\/jem.20130706","volume":"210","author":"M Scheller","year":"2013","unstructured":"Scheller M, Schonheit J, Zimmermann K, Leser U, Rosenbauer F, Leutz A (2013) Cross talk between Wnt\/beta-catenin and Irf8 in leukemia progression and drug resistance. J Exp Med 210:2239\u20132256","journal-title":"J Exp Med"},{"key":"9_CR88","doi-asserted-by":"publisher","first-page":"cm8","DOI":"10.1126\/stke.4072007cm8","volume":"2007","author":"GL Semenza","year":"2007","unstructured":"Semenza GL (2007) Hypoxia-inducible factor 1 (HIF-1) pathway. Sci STKE 2007:cm8","journal-title":"Sci STKE"},{"key":"9_CR89","doi-asserted-by":"publisher","first-page":"3051","DOI":"10.1128\/MCB.19.4.3051","volume":"19","author":"WF Shen","year":"1999","unstructured":"Shen WF, Rozenfeld S, Kwong A, ves Kom LG, Lawrence HJ, Largman C (1999) HOXA9 forms triple complexes with PBX2 and MEIS1 in myeloid cells. Mol Cell Biol 19:3051\u20133061","journal-title":"Mol Cell Biol"},{"key":"9_CR90","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.jmb.2011.12.002","volume":"415","author":"N Siddiqui","year":"2012","unstructured":"Siddiqui N, Tempel W, Nedyalkova L, Volpon L, Wernimont AK, Osborne MJ, Park HW, Borden KL (2012) Structural insights into the allosteric effects of 4EBP1 on the eukaryotic translation initiation factor eIF4E. J Mol Biol 415:781\u2013792","journal-title":"J Mol Biol"},{"key":"9_CR91","doi-asserted-by":"publisher","first-page":"3949","DOI":"10.1038\/onc.2009.252","volume":"28","author":"A Soeda","year":"2009","unstructured":"Soeda A, Park M, Lee D, Mintz A, Androutsellis-Theotokis A, McKay RD, Engh J, Iwama T, Kunisada T, Kassam AB et al (2009) Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1alpha. Oncogene 28:3949\u20133959","journal-title":"Oncogene"},{"key":"9_CR92","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1182\/blood.V99.6.1928","volume":"99","author":"M Talpaz","year":"2002","unstructured":"Talpaz M, Silver RT, Druker BJ, Goldman JM, Gambacorti-Passerini C, Guilhot F, Schiffer CA, Fischer T, Deininger MW, Lennard AL et al (2002) Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 study. Blood 99:1928\u20131937","journal-title":"Blood"},{"key":"9_CR93","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1084\/jem.179.1.167","volume":"179","author":"T Tauchi","year":"1994","unstructured":"Tauchi T, Boswell HS, Leibowitz D, Broxmeyer HE (1994) Coupling between p210bcr-abl and Shc and Grb2 adaptor proteins in hematopoietic cells permits growth factor receptor-independent link to ras activation pathway. J Exp Med 179:167\u2013175","journal-title":"J Exp Med"},{"key":"9_CR94","first-page":"181","volume":"1805","author":"S Teglund","year":"2010","unstructured":"Teglund S, Toftgard R (2010) Hedgehog beyond medulloblastoma and basal cell carcinoma. Biochim Biophys Acta 1805:181\u2013208","journal-title":"Biochim Biophys Acta"},{"key":"9_CR95","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1146\/annurev.cellbio.13.1.513","volume":"13","author":"SM Thomas","year":"1997","unstructured":"Thomas SM, Brugge JS (1997) Cellular functions regulated by Src family kinases. Annu Rev Cell Dev Biol 13:513\u2013609","journal-title":"Annu Rev Cell Dev Biol"},{"key":"9_CR96","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.stem.2011.02.006","volume":"8","author":"Y Wang","year":"2011","unstructured":"Wang Y, Liu Y, Malek SN, Zheng P, Liu Y (2011) Targeting HIF1alpha eliminates cancer stem cells in hematological malignancies. Cell Stem Cell 8:399\u2013411","journal-title":"Cell Stem Cell"},{"key":"9_CR97","doi-asserted-by":"publisher","first-page":"4898","DOI":"10.1158\/0008-5472.CAN-12-4277","volume":"73","author":"J Yang","year":"2013","unstructured":"Yang J, Wang J, Chen K, Guo G, Xi R, Rothman PB, Whitten D, Zhang L, Huang S, Chen JL (2013) eIF4B phosphorylation by pim kinases plays a critical role in cellular transformation by Abl oncogenes. Cancer Res 73:4898\u20134908","journal-title":"Cancer Res"},{"key":"9_CR98","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.ccr.2010.03.011","volume":"17","author":"B Zhang","year":"2010","unstructured":"Zhang B, Strauss AC, Chu S, Li M, Ho Y, Shiang KD, Snyder DS, Huettner CS, Shultz L, Holyoake T et al (2010) Effective targeting of quiescent chronic myelogenous leukemia stem cells by histone deacetylase inhibitors in combination with imatinib mesylate. Cancer Cell 17:427\u2013442","journal-title":"Cancer Cell"},{"key":"9_CR99","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1128\/MCB.05672-11","volume":"32","author":"H Zhang","year":"2012","unstructured":"Zhang H, Li H, Ho N, Li D, Li S (2012a) Scd1 plays a tumor-suppressive role in survival of leukemia stem cells and the development of chronic myeloid leukemia. Mol Cell Biol 32:1776\u20131787","journal-title":"Mol Cell Biol"},{"key":"9_CR100","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.1182\/blood-2011-10-387381","volume":"119","author":"H Zhang","year":"2012","unstructured":"Zhang H, Li H, Xi HS, Li S (2012b) HIF1alpha is required for survival maintenance of chronic myeloid leukemia stem cells. Blood 119:2595\u20132607","journal-title":"Blood"},{"key":"9_CR101","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/ng.2350","volume":"44","author":"H Zhang","year":"2012","unstructured":"Zhang H, Peng C, Hu Y, Li H, Sheng Z, Chen Y, Sullivan C, Cerny J, Hutchinson L, Higgins A et al (2012c) The Blk pathway functions as a tumor suppressor in chronic myeloid leukemia stem cells. Nat Genet 44:861\u2013871","journal-title":"Nat Genet"},{"key":"9_CR102","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.ccr.2007.11.003","volume":"12","author":"C Zhao","year":"2007","unstructured":"Zhao C, Blum J, Chen A, Kwon HY, Jung SH, Cook JM, Lagoo A, Reya T (2007) Loss of beta-catenin impairs the renewal of normal and CML stem cells in vivo. Cancer Cell 12:528\u2013541","journal-title":"Cancer Cell"},{"key":"9_CR103","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/nature07737","volume":"458","author":"C Zhao","year":"2009","unstructured":"Zhao C, Chen A, Jamieson CH, Fereshteh M, Abrahamsson A, Blum J, Kwon HY, Kim J, Chute JP, Rizzieri D et al (2009) Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia. Nature 458:776\u2013779","journal-title":"Nature"},{"key":"9_CR104","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s13238-015-0143-7","volume":"6","author":"H Zhou","year":"2015","unstructured":"Zhou H, Xu R (2015) Leukemia stem cells: the root of chronic myeloid leukemia. Protein Cell 6:403\u2013412","journal-title":"Protein Cell"},{"key":"9_CR105","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1002\/emmm.201201760","volume":"5","author":"J Zhu","year":"2013","unstructured":"Zhu J, Zhou L, Wu G, Konig H, Lin X, Li G, Qiu XL, Chen CF, Hu CM, Goldblatt E et al (2013) A novel small molecule RAD51 inactivator overcomes imatinib-resistance in chronic myeloid leukaemia. EMBO Mol Med 5:353\u2013365","journal-title":"EMBO Mol Med"}],"container-title":["Advances in Experimental Medicine and Biology","Leukemia Stem Cells in Hematologic Malignancies"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-981-13-7342-8_9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T01:16:48Z","timestamp":1610587008000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-981-13-7342-8_9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9789811373411","9789811373428"],"references-count":105,"URL":"https:\/\/doi.org\/10.1007\/978-981-13-7342-8_9","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"24 July 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}